Acute Hepatic Porphyria (AHP)

International Congress of Inborn Errors Metabolism (ICIEM) 2025

Congress Details

calander2-6 September 2025 | Japan

locationKyoto, Japan

The materials in this section are intended for UK healthcare professionals and include scientific and educational congress content related to givosiran▼. The information contained in these presentations and posters was accurate at the time of presentation. Healthcare professionals should consult the current full Prescribing Information [for the most up-to-date information on indications, dosing, contraindications, warnings, and adverse reactions].

Oral

Congress Materials

iciem
icon Presentation Type
Presentation
location icon Location
Kyoto, Japan
icon Title
Long-term clinical outcomes of patients with acute hepatic porphyria who were not attack-free after 6 months of givosiran treatment in a subgroup analysis of the phase 3 ENVISION study

Associated Materials

ips-congress-usa-mobile

Acute Hepatic Porphyria (AHP)

American Association for the Study of Liver Diseases (AASLD) 2025

7-11 November 2025 USA

View Details
Preparation Date
March 2026
Job Code
MB-UK-00084
ips-congress-usa-mobile

Acute Hepatic Porphyria (AHP)

International Porphyrias Symposium (IPS) 2025

9-12 October 2025 USA

View Details
Preparation Date
March 2026
Job Code
MB-UK-00087

Acute Hepatic Porphyria (AHP)

Patient experience with acute hepatic porphyria before and after long-term givosiran treatment in a qualitative interview study

Molecular Genetics and Metabolism Reports

Author(s)

Hetanshi Naik, Michelle Brown, Stephen Meninger, et al

March 2025

Preparation Date
March 2026
Job Code
MB-UK-00175
Preparation Date
March 2026
Job Code
MB-UK-00090